Introduction Conference of sultamicillin for suspension

On July 10, 2016, a symposium on systemic clinical evaluation and experimental research of antibacterial medicines was held in Shanghai, "Clinic Pathway Interpretation" Infectious Diseases Catalog Editorial Board ", Shenzhen Beimei Pharmaceutical Co., Ltd., as co-sponsor, held the" Recommendation Meeting for sultamicillin for suspension ",Professor Zheng Bo, an expert in the Department of Anti-Infectious Diseases of Peking University First Hospital, was invited to explain the pharmacological effects and experience of sultamicillin for suspension.